Krystal Biotech Inc. (KRYS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Krystal Biotech Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Krystal Biotech Inc. (KRYS) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $9.5B. It trades at $321.42, up 0.26% today. 8 analysts' average target of $403.50 implies +25.5% from today's price. Kronos AI's 30-day forecast is +3.1% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $403.50 |
| Low – high | $361.00 – $441.00 |
| Analysts | 8 |
| Upside to average | +25.5% |
Kronos AI 30-day forecast
| Expected close | $330.69 (+3.1%) |
| Likely range | −1.9% … +7.3% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator